Boston Scientific's Lotus replacement heart valve shows low leakage rates and no instances of moderate or severe leakage, a problem that plagued the earlier generation of transcatheter aortic valve implants.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BJ9L7K
Cap comentari:
Publica un comentari a l'entrada